Tenax Therapeut

TENX NASDAQ
1.130
-0.030
-2.59%
已收盘, 16:00 08/19 EDT
开盘
1.140
昨收
1.160
最高
1.200
最低
1.125
成交量
4.09万
成交均量(3M)
9.02万
52周最高
6.39
52周最低
1.030
换手率
0.61%
市值
761.83万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Tenax Therapeut TENX股票价格,Tenax Therapeut股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
展开 >

最近浏览

名称
价格
涨跌幅